March arabica coffee (KCH26 ) on Friday closed down -6.90 (-1.83%), and January ICE robusta coffee (RMF26 ) closed down -84 (-2.00%). Coffee prices fell sharply on Friday, with robusta posting a 2.5-month low. The outlook for ample coffee supplies i...
The U.S. is adding $1 trillion in new debt every 100 days. The Fed can either induce a melt-up via inflation… or let the bond bubble burst, triggering a crisis.
The financial markets are currently witnessing an intriguing and somewhat counter-intuitive phenomenon: a significant surge in both gold prices and U.S. Treasuries. This dual rally, particularly the simultaneous rise of gold and falling Treasury yields (indicating rising bond prices), signals a profound shift in investor sentiment, driven by a
GameStop stock is trading lower this week, down approximately 7% over the past five days to sit near $21.50, as investors react to a mixed Q3 financial report.
The Federal Reserve delivered its third consecutive interest rate cut on December 10, 2025, reducing its benchmark federal funds rate by 0.25 percentage points to a target range of 3.50% to 3.75%. This highly anticipated move aimed to bolster a weakening labor market and navigate persistent, albeit
The U.S. stock market is currently experiencing a striking divergence in performance, with the venerable Dow Jones Industrial Average and the broad-based S&P 500 Index ascending to unprecedented record highs, while the technology-heavy Nasdaq Composite finds itself struggling in their wake. This "Great Divergence," observed around December 12,
Broadcom's (NASDAQ: AVGO) recent earnings report for the fourth quarter and fiscal year 2025, released on December 11, 2025, presented a paradox to the financial markets. Despite exceeding its own guidance and analyst expectations with robust revenue and profit growth, and a significant surge in AI semiconductor revenue, the semiconductor
Stay informed about the most active stocks in the S&P500 index on Friday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Aardvark Therapeutics gains an Outperform rating as its Phase 3 PWS trial progresses and analysts point to large market potential for ARD-101 and ARD-201.
The exhilarating surge in Artificial Intelligence (AI) related stocks, a defining feature of the 2025 financial landscape, has hit a significant roadblock. As of December 2025, the market is witnessing a pronounced selloff in the technology sector, particularly impacting companies at the forefront of AI innovation. This downturn is fueled
Heart disease-focused Tenaya Therapeutics falls on high volume after pricing a $60 million offering and releasing new TN-401 data, while the FDA clears the TN-201 trial hold.
EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in the U.S., U.K., and other markets.
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
Semiconductor production equipment provider Amtech Systems (NASDAQ:ASYS) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 17.7% year on year to $19.84 million. On the other hand, next quarter’s revenue guidance of $19 million was less impressive, coming in 2.6% below analysts’ estimates. Its non-GAAP profit of $0.10 per share was significantly above analysts’ consensus estimates.
Manufacturing company Nordson (NASDAQ:NDSN) fell short of the markets revenue expectations in Q3 CY2025, with sales flat year on year at $751.8 million. Next quarter’s revenue guidance of $650 million underwhelmed, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $3.03 per share was 3.4% above analysts’ consensus estimates.
The S&P 500 was able to achieve a fresh all-time closing high yesterday thanks to a powerful move from tech stocks into more cyclical and rate-sensitive sectors.
Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC data and key 2026 milestones.
Action on Visa stock was busy in Thursday's trading. Share volume was nearly double its 30-day average, and options volume was almost three times the monthly average. More importantly, its unusual options activity offers three ways for investors to p...
VivoPower shares jumped after the company announced a Ripple-focused joint venture that offers capital-light exposure to digital assets through South Korean investors.
